SAREPTA THERAPEUTICS, INC. Operating Leases, Future Minimum Payments, Due in Four Years
SAREPTA THERAPEUTICS, INC. (SRPT) had Operating Leases, Future Minimum Payments, Due in Four Years of $10.90 million as of 2018-12-31, per its 10-K filed 2020-02-26.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears · last filed 2020-02-26
- 2018-12-31: Operating Leases, Future Minimum Payments, Due in Four Years $10.90M; Operating Leases, Future Minimum Payments, Due in Four Years as first filed $10.76M.
- 2018-09-30: Operating Leases, Future Minimum Payments, Due in Four Years $8.67M.
- 2018-06-30: Operating Leases, Future Minimum Payments, Due in Four Years $8.57M.
- 2017-12-31: Operating Leases, Future Minimum Payments, Due in Four Years $332.00K.
| Period end | Operating Leases, Future Minimum Payments, Due in Four Years | Operating Leases, Future Minimum Payments, Due in Four Years as first filed |
|---|---|---|
| 2018-12-31 | $10.90M 10-K · filed 2020-02-26 | $10.76M 10-K · filed 2019-02-28 |
| 2018-09-30 | $8.67M 10-Q · filed 2018-10-31 | |
| 2018-06-30 | $8.57M 10-Q · filed 2018-08-08 | |
| 2017-12-31 | $332.00K 10-K · filed 2018-03-01 | |
| 2016-12-31 | $5.10M 10-K · filed 2017-02-28 | |
| 2015-12-31 | $4.97M 10-K · filed 2016-02-25 | |
| 2014-12-31 | $4.85M 10-K · filed 2015-02-26 | |
| 2014-09-30 | $4.54M 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $4.37M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $4.08M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $3.99M 10-K · filed 2014-03-03 | |
| 2012-12-31 | $1.46M 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |